Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) Director Matthew Shawn Morris sold 10,309 shares of the firm’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the sale, the director now owns 59,792 shares of the company’s stock, valued at approximately $1,394,947.36. The trade was a 14.71 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Privia Health Group Stock Performance
PRVA stock opened at $23.32 on Friday. The stock’s 50 day moving average price is $23.50 and its 200 day moving average price is $22.10. The firm has a market cap of $2.83 billion, a P/E ratio of 233.22, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04.
Analyst Upgrades and Downgrades
Several research firms have recently commented on PRVA. Robert W. Baird raised their price target on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. Truist Financial boosted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Barclays increased their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Thursday, April 10th. JMP Securities reissued a “market outperform” rating and set a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. Finally, Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 28th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Buy” and an average target price of $27.38.
Institutional Trading of Privia Health Group
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Quadrant Capital Group LLC increased its position in Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after purchasing an additional 511 shares in the last quarter. Park Avenue Securities LLC raised its position in shares of Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after buying an additional 532 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock valued at $140,000 after buying an additional 533 shares during the period. CWM LLC boosted its position in Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its stake in Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares during the period. 94.48% of the stock is currently owned by hedge funds and other institutional investors.
About Privia Health Group
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
- Five stocks we like better than Privia Health Group
- Bank Stocks – Best Bank Stocks to Invest In
- Magnificent 7 Stocks Send a Dire Warning to Markets
- Investing In Automotive Stocks
- Why Spotify Stock Still Has Room to Run in 2025
- What is the NASDAQ Stock Exchange?
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.